Sten Nilsson

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

I. Tannock, M. Rubin, A. Chinnaiyan, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Alpha emitter radium-223 and survival in metastatic prostate cancer.

I Syndikus, J Kliment, S. Fosså, 2013, The New England journal of medicine.

Prostate cancer: ESMO Consensus Conference Guidelines 2012.

T. D. de Reijke, D. Dearnaley, A. Horwich, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223

M. Kattan, C. Parker, S. Nilsson, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study

C. Parker, J. Reuning-Scherer, S. Nilsson, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Overall survival benefit and safety profile of radium-223 chloride, a first-in-class alpha-pharmaceutical: Results from a phase III randomized trial (ALSYMPCA) in patients with castration-resistant prostate cancer (CRPC) with bone metastases.

N. James, A. Cross, Chris Parker, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

I. Tannock, M. Rubin, A. Chinnaiyan, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.